MUFG Americas Holdings Corp Sells 2,559 Shares of Clorox Co (CLX)

Share on StockTwits

MUFG Americas Holdings Corp lessened its stake in shares of Clorox Co (NYSE:CLX) by 36.7% during the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 4,418 shares of the company’s stock after selling 2,559 shares during the quarter. MUFG Americas Holdings Corp’s holdings in Clorox were worth $665,000 at the end of the most recent quarter.

A number of other large investors also recently added to or reduced their stakes in the stock. Pacer Advisors Inc. grew its position in shares of Clorox by 18.7% during the 3rd quarter. Pacer Advisors Inc. now owns 7,037 shares of the company’s stock worth $1,058,000 after buying an additional 1,108 shares in the last quarter. Martin Capital Partners LLC bought a new position in shares of Clorox during the 3rd quarter worth $409,000. Paloma Partners Management Co bought a new position in shares of Clorox during the 3rd quarter worth $2,480,000. Bell Rock Capital LLC bought a new position in shares of Clorox during the 3rd quarter worth $1,422,000. Finally, LPL Financial LLC grew its position in shares of Clorox by 7.6% during the 3rd quarter. LPL Financial LLC now owns 108,345 shares of the company’s stock worth $16,296,000 after buying an additional 7,625 shares in the last quarter. Institutional investors own 77.96% of the company’s stock.

Shares of CLX stock opened at $164.52 on Friday. Clorox Co has a 1-year low of $113.57 and a 1-year high of $167.70. The stock has a market cap of $21.00 billion, a P/E ratio of 26.28, a P/E/G ratio of 4.04 and a beta of 0.30. The company has a debt-to-equity ratio of 3.38, a quick ratio of 0.65 and a current ratio of 1.07.

Clorox (NYSE:CLX) last issued its quarterly earnings data on Wednesday, October 31st. The company reported $1.62 earnings per share for the quarter, beating analysts’ consensus estimates of $1.59 by $0.03. Clorox had a return on equity of 102.65% and a net margin of 13.59%. The company had revenue of $1.56 billion for the quarter, compared to the consensus estimate of $1.53 billion. During the same quarter last year, the company earned $1.46 earnings per share. The firm’s revenue for the quarter was up 4.2% compared to the same quarter last year. On average, equities analysts anticipate that Clorox Co will post 6.31 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 8th. Shareholders of record on Wednesday, January 23rd will be paid a $0.96 dividend. This represents a $3.84 dividend on an annualized basis and a yield of 2.33%. The ex-dividend date is Tuesday, January 22nd. Clorox’s dividend payout ratio (DPR) is presently 61.34%.

In other Clorox news, SVP Michael R. Costello sold 6,882 shares of the stock in a transaction dated Thursday, November 15th. The stock was sold at an average price of $160.08, for a total value of $1,101,670.56. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Benno O. Dorer sold 152,449 shares of the stock in a transaction dated Tuesday, December 4th. The shares were sold at an average price of $164.83, for a total value of $25,128,168.67. Following the completion of the sale, the chief executive officer now owns 111,735 shares of the company’s stock, valued at $18,417,280.05. The disclosure for this sale can be found here. Over the last quarter, insiders sold 287,911 shares of company stock valued at $46,842,570. 1.40% of the stock is currently owned by company insiders.

CLX has been the topic of a number of recent research reports. Zacks Investment Research raised Clorox from a “hold” rating to a “buy” rating and set a $171.00 price target on the stock in a research report on Wednesday, October 3rd. Argus raised Clorox from a “hold” rating to a “buy” rating and set a $175.00 price objective on the stock in a research report on Tuesday, September 25th. ValuEngine raised Clorox from a “hold” rating to a “buy” rating in a research report on Saturday, September 22nd. BMO Capital Markets raised their price objective on Clorox from $153.00 to $165.00 and gave the company a “buy” rating in a research report on Friday, November 2nd. Finally, Barclays set a $131.00 price objective on Clorox and gave the company a “hold” rating in a research report on Saturday, October 6th. Four investment analysts have rated the stock with a sell rating, eight have given a hold rating and three have issued a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average target price of $146.00.

TRADEMARK VIOLATION NOTICE: “MUFG Americas Holdings Corp Sells 2,559 Shares of Clorox Co (CLX)” was reported by BBNS and is the sole property of of BBNS. If you are viewing this news story on another website, it was stolen and reposted in violation of US & international copyright and trademark legislation. The legal version of this news story can be accessed at https://baseballnewssource.com/2018/12/16/mufg-americas-holdings-corp-sells-2559-shares-of-clorox-co-clx/3084890.html.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.

See Also: What are CEFs?

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2019 BBNS.